These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 21194662)
1. Phase II study of the novel peptide-nucleic acid OHR118 in the management of cancer-related anorexia/cachexia. Chasen M; Hirschman SZ; Bhargava R J Am Med Dir Assoc; 2011 Jan; 12(1):62-7. PubMed ID: 21194662 [TBL] [Abstract][Full Text] [Related]
2. Phase II trial of mirtazapine for cancer-related cachexia and anorexia. Riechelmann RP; Burman D; Tannock IF; Rodin G; Zimmermann C Am J Hosp Palliat Care; 2010 Mar; 27(2):106-10. PubMed ID: 19776373 [TBL] [Abstract][Full Text] [Related]
3. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753 [TBL] [Abstract][Full Text] [Related]
4. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. Loprinzi CL; Michalak JC; Schaid DJ; Mailliard JA; Athmann LM; Goldberg RM; Tschetter LK; Hatfield AK; Morton RF J Clin Oncol; 1993 Apr; 11(4):762-7. PubMed ID: 8478668 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of Yukgunja-Tang for treating anorexia in patients with cancer: The protocol for a pilot, randomized, controlled trial. Kang HJ; Jeong MK; Park SJ; Jun HJ; Yoo HS Medicine (Baltimore); 2019 Oct; 98(40):e16950. PubMed ID: 31577697 [TBL] [Abstract][Full Text] [Related]
6. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia. Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456 [TBL] [Abstract][Full Text] [Related]
7. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. Loprinzi CL; Ellison NM; Schaid DJ; Krook JE; Athmann LM; Dose AM; Mailliard JA; Johnson PS; Ebbert LP; Geeraerts LH J Natl Cancer Inst; 1990 Jul; 82(13):1127-32. PubMed ID: 2193166 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacological therapy of cancer anorexia-cachexia]. Cardona D Nutr Hosp; 2006 May; 21 Suppl 3():17-26. PubMed ID: 16768027 [TBL] [Abstract][Full Text] [Related]
9. The Bristol-Myers Anorexia/Cachexia Recovery Instrument (BACRI): a brief assessment of patients' subjective response to treatment for anorexia/cachexia. Cella DF; VonRoenn J; Lloyd S; Browder HP Qual Life Res; 1995 Jun; 4(3):221-31. PubMed ID: 7613532 [TBL] [Abstract][Full Text] [Related]
10. Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia. Yavuzsen T; Walsh D; Davis MP; Kirkova J; Jin T; LeGrand S; Lagman R; Bicanovsky L; Estfan B; Cheema B; Haddad A Support Care Cancer; 2009 Dec; 17(12):1531-41. PubMed ID: 19350287 [TBL] [Abstract][Full Text] [Related]
11. The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study. Yennurajalingam S; Willey JS; Palmer JL; Allo J; Del Fabbro E; Cohen EN; Tin S; Reuben JM; Bruera E J Palliat Med; 2012 Oct; 15(10):1059-64. PubMed ID: 22880820 [TBL] [Abstract][Full Text] [Related]
12. Audit of symptoms and prescribing in patients with the anorexia-cachexia syndrome. Andrew I; Kirkpatrick G; Holden K; Hawkins C Pharm World Sci; 2008 Oct; 30(5):489-96. PubMed ID: 18246443 [TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; Krook JE; Wilwerding MB; Rowland KM; Camoriano JK; Novotny PJ; Christensen BJ J Clin Oncol; 1999 Oct; 17(10):3299-306. PubMed ID: 10506633 [TBL] [Abstract][Full Text] [Related]
14. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer. Gebbia V; Testa A; Gebbia N Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133 [TBL] [Abstract][Full Text] [Related]
15. A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index. Naito T; Uchino J; Kojima T; Matano Y; Minato K; Tanaka K; Mizukami T; Atagi S; Higashiguchi T; Muro K; Takayama K; Furuse J; Morishima E; Takiguchi T; Tamura K Cancer; 2022 May; 128(10):2025-2035. PubMed ID: 35195274 [TBL] [Abstract][Full Text] [Related]
16. Cachexia and anorexia: cancer's covert killer. Davis MP; Dickerson D Support Care Cancer; 2000 May; 8(3):180-7. PubMed ID: 10789957 [TBL] [Abstract][Full Text] [Related]
17. Randomized trials of megestrol acetate for AIDS-associated anorexia and cachexia. Von Roenn JH Oncology; 1994 Oct; 51 Suppl 1():19-24. PubMed ID: 7970504 [TBL] [Abstract][Full Text] [Related]
18. Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial. De Conno F; Martini C; Zecca E; Balzarini A; Venturino P; Groff L; Caraceni A Eur J Cancer; 1998 Oct; 34(11):1705-9. PubMed ID: 9893656 [TBL] [Abstract][Full Text] [Related]
19. A Phase II dose titration study of thalidomide for cancer-associated anorexia. Davis M; Lasheen W; Walsh D; Mahmoud F; Bicanovsky L; Lagman R J Pain Symptom Manage; 2012 Jan; 43(1):78-86. PubMed ID: 21640548 [TBL] [Abstract][Full Text] [Related]
20. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials. Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]